Guardant Health
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Guardant Health generated cash of -$324,975,000, which is less than the previous year. Cash used in financing activities reached the amount of $477,375,000 last year. Net change in cash is therefore $991,739,000.
Cash Flow
| 2016 | -36.71M | 26.20M | 39.84M |
|---|---|---|---|
| 2017 | -72.23M | -170.41M | 281.65M |
| 2018 | -72.18M | -153.02M | 293.16M |
| 2019 | -47.13M | -317.57M | 367.30M |
| 2020 | -103.92M | -617.08M | 1.41B |
| 2021 | -209.01M | -63.15M | -66.82M |
| 2022 | -309.46M | 149.81M | -189.09M |
| 2023 | -324.97M | 840.25M | 477.37M |
GH Cash Flow Statement (2016 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 141.94M | 492.28M | 832.97M | 143.22M | 140.54M | 72.59M | 33.59M | 4.25M |
Operating activities | ||||||||
Net income | -479.44M | -654.58M | -384.77M | -246.28M | -67.85M | -84.26M | -83.22M | -46.13M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||
Depreciation and amortization | 42.88M | 35.96M | 22.27M | 16.06M | 13.60M | 7.13M | 5.20M | 3.69M |
Stock-based compensation expense | 90.75M | 94.68M | 151.44M | 144.11M | 16.95M | 6.85M | 3.67M | 1.97M |
| Deferred income tax benefit | 90.75M | 94.68M | 151.44M | 144.11M | 16.95M | 6.85M | 3.67M | 1.97M |
| Changes in operating assets and liabilities: | ||||||||
Accounts receivable, net | 8.37M | 375K | -44.35M | -5.46M | -7.38M | -22.90M | -9.29M | -2.78M |
Inventories | -10.35M | -20.92M | -7.95M | -7.53M | -6.04M | -1.84M | -4.51M | -351K |
Accounts payable | 88.59M | 60.32M | 8.63M | -7.85M | 4.34M | 5.04M | 1.25M | 2.14M |
Cash generated by operating activities | -324.97M | -309.46M | -209.01M | -103.92M | -47.13M | -72.18M | -72.23M | -36.71M |
Investing activities | ||||||||
Purchases Of Investments | -635.49M | -327.72M | -940.23M | -1.12B | -614.29M | -287.45M | -236.83M | -341.41M |
Investments In Property Plant And Equipment | -20.48M | -77.46M | -75.03M | -54.05M | -21.28M | -20.20M | -8.98M | -1.76M |
Acquisitions Net | 0 | -227.27M | -11.88M | 17.88M | -7.32M | 0 | 2.30M | 0 |
Cash generated by investing activities | 840.25M | 149.81M | -63.15M | -617.08M | -317.57M | -153.02M | -170.41M | 26.20M |
Financing activities | ||||||||
Common Stock Issued | 493.11M | 11.94M | 17.86M | 355.73M | 350.43M | 254.00M | 765K | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | -3.15M | 0 | 0 |
Repurchases of common stock | 10.15M | -7.87M | -83.75M | 7.09M | 0 | -172K | -12.55M | -100K |
Repayments of term debt | 0 | -71K | -930K | -174K | -127K | -443K | -26.08M | -379K |
Cash used in financing activities | 477.37M | -189.09M | -66.82M | 1.41B | 367.30M | 293.16M | 281.65M | 39.84M |
Net Change In Cash | 991.73M | -842.62M | -340.68M | 689.74M | 2.68M | 67.94M | 39.00M | 29.33M |
Cash at end of period | 1.13B | -350.34M | 492.28M | 832.97M | 143.22M | 140.54M | 72.59M | 33.59M |
| Data source | Data source | Data source | Data source | Data source | Data source |